FDA.reportPublic FDA data

24 HR diltiazem hydrochloride 300 MG Extended Release Oral Tablet [Matzim]

RxCUI
1091635
RxNorm name
24 HR diltiazem hydrochloride 300 MG Extended Release Oral Tablet [Matzim]
Display name
24 HR diltiazem hydrochloride 300 MG Extended Release Oral Tablet [Matzim]
Full name
24 HR diltiazem hydrochloride 300 MG Extended Release Oral Tablet [Matzim]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e8c8dd18-9d95-4068-9762-bec1eb1bc25cMatzim LA 300 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR diltiazem hydrochloride 300 MG Extended Release Oral Tablet [Matzim] [SBD] · 24 HR Matzim 300 MG Extended Release Oral Tablet [SY] · Matzim LA 300 MG 24 HR Extended Release Oral Tablet [SY]413These highlights do not include all the information needed to use MATZIM LA (DILTIAZEM HYDROCHLORIDE) EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MATZIM LA (DILTIAZEM HYDROCHLORIDE) EXTENDED-RELEASE TABLETS. Matzim ® LA (DILTIAZEM HYDROCHLORIDE) extended-release tablets, for oral use Initial U.S. Approval: 198220250501